Navigation Links
Blacks With Certain Gene Need Lower Doses of Warfarin: Study
Date:6/5/2013

WEDNESDAY, June 5 (HealthDay News) -- The discovery of a genetic variation that affects how some black patients respond to the blood thinner warfarin could improve the safety and effectiveness of the drug, researchers report.

Blacks with this common genetic variation need a significantly lower dose of warfarin than those without the variation, the researchers report online June 4 in The Lancet.

"Adding this genetic marker -- found in more than 40 percent of African-American patients in the study -- to standard dosing algorithms improved the predictability of warfarin dosing by 21 percent in these individuals, which has the potential to increase the safety and effectiveness of this notoriously hard-to- dose drug," study leader Julie Johnson, of the University of Florida, said in a journal news release.

Warfarin is widely used to prevent blood clots in patients with a heart rhythm disorder called atrial fibrillation, a history of previous blood clots and after major surgery. However, it can be difficult to determine the correct dose for individual patients.

Previous research has identified two genes that explain about 30 percent of the difference in warfarin response in people of European and Asian ancestry, but these genes have less of an effect in blacks.

In this study, the researchers analyzed health information and DNA samples from hundreds of blacks and determined that there was a strong association between the rs12777823 variant on chromosome 10 and warfarin dose. The findings suggest that the dose of warfarin required by blacks with one or two copies of this variant is about 7 milligrams (mg) to 9 mg less per week than for other patients, the researchers said.

The U.S. Food and Drug Administration advocates use of genetic backgrounds to help guide warfarin dosing, Mark Alberts, of the University of Texas Southwestern Medical Center at Dallas and author of an accompanying editorial, said in the news release. "However, the practical aspects [and limitations] have not been fully appreciated.

"Genetic testing has several challenges: it is not widely available in some areas; it is costly; and clinicians often can identify the correct dose before test results are available. If these problems were corrected, the actual use of such tests might increase substantially," Alberts noted.

More information

The American Heart Association has more about warfarin.

-- Robert Preidt

SOURCE: The Lancet, news release, June 4, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. High Blood Pressure May Be Especially Lethal for Blacks
2. Hispanic lung cancer patients tend to live longer than blacks and whites
3. Blacks and Hispanics at higher risk for precancerous colorectal polyps
4. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
5. Eye Changes May Predict Heart Disease in Blacks With Diabetes
6. Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought
7. 9 in 10 Blacks With High Blood Pressure Have Early Heart Disease
8. Marriage has different meanings for blacks and whites
9. Blacks More Prone to Hypertension After Certain Strokes
10. Stress Adds to Salt Load of Some Blacks, Study Says
11. Blacks Less Likely to Stick to High Blood Pressure Diet: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blacks With Certain Gene Need Lower Doses of Warfarin: Study
(Date:4/30/2016)... , ... April 30, 2016 , ... Orlando-based Maximized Living ... they go for gold in Rio. Under the care of Maximized Living doctors ... , In an unprecedented showing, Maximized Living is sending the largest contingent of elite ...
(Date:4/29/2016)... ... April 29, 2016 , ... Since launching its annual volunteer ... serving the footwear industry, has broken all previous participation records in its first ... 23 states during the months of April and May, the 2016 Footwear Cares ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) ... with sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, ... Run and Walk and 1-mile walk were held to increase awareness about Lyme ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award for ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... 27, 2016  Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended March 26, ... $0.24 increased 41.2%, and non-GAAP diluted EPS of ... 5.8% on a reported basis, and 6.3% on ... posted another good quarter, highlighted by 14.6% growth ...
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
Breaking Medicine Technology: